F. Ong - Concepedia

Author

F. Ong

Netherlands Comprehensive Cancer Organisation ORCID

Also Known As

F ONG, F Ong, F. Ong, Francesca Yi Teng Ong, Ong, F., Ong, Francisca

Publications

548

Citations

H-Index

Concepts

All Affiliations

Netherlands Comprehensive Cancer Organisation Leiden University Leiden University Medical Center Rijnstate Hospital Medisch Spectrum Twente

About

F. Ong is an author at Netherlands Comprehensive Cancer Organisation specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	231
2	Engineering	2	2	29
3	Health Sciences	1	1	92
4	Public Health	1	1	10
5	Biostatistics	1	1	13

F. Ong

Publications

491

Citations

H-Index

Page 1

	Year	Citations
International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades J. Hermans, K. van Groningen, PM Kluin, Blood	1995	144
Synchronous, bilateral breast cancer: prognostic value and incidence Jan J. Jobsen, Job van der Palen, F. Ong, The Breast Worse DssBreast OncologyMedicineCancer RecurrenceBrachytherapy	2003	92
Bilateral breast cancer, synchronous and metachronous; differences and outcome Jan J. Jobsen, Job van der Palen, F. Ong, Breast Cancer Research and Treatment Surgical OncologyBreast OncologyMedicineBreast ImagingBreast Cancer	2015	88
Bcl-2 protein expression is not related to short survival in multiple myeloma. F. Ong, J. A. van Nieuwkoop, G M de Groot-Swings, PubMed	1995	36
A population‐based registry on paraproteinaemia in the Netherlands F. Ong, J. Hermans, E.M. Noordijk, British Journal of Haematology	1997	32
Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes F. Ong, Ulrich Kaiser, P.J. Seelen, Blood	1996	20
Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms F. Ong, J. Hermans, E.M. Noordijk, Annals of Hematology Hematological MalignancyMalignant Blood DisorderHematologyPathologyMultiple Myeloma	1995	17
Detection and absolute quantification biosensing tools for food authentication: CRISPR/Cas, digital CRISPR and beyond Xiaolin Wu, Xuanming Lou, Hanzhang Zhou, Trends in Food Science & Technology EngineeringFood AuthenticationBiosensing SystemsDigital CrisprBiomolecular Tool	2024	16
Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? F. Ong, J. Hermans, E.M. Noordijk, Annals of Hematology Medical DiagnosticsPlasma Cell DyscrasiasEngineeringMedicineDiagnostic Test	1995	13
The impact of margin status in breast-conserving therapy for lobular carcinoma is age related Jan J. Jobsen, Sietske A. Riemersma, Job van der Palen, European Journal of Surgical Oncology Surgical OncologyBreast OncologyMedicineMargin StatusLobular Carcinoma	2009	12

Page 1